Richard Ma
Impact in
- Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases
- Microbial Natural Products and Biosynthesis
- Organic Chemistry top 5%
- Chemical synthesis and alkaloids
Papers in
- Pharmacology 14
- Cholinesterase and Neurodegenerative Diseases 14
- Ginger and Zingiberaceae research 3
-
- Plant Toxicity and Pharmacological Properties 3
- Co-authors
- David R. Gang (10 shared papers)Chang‐Heng Tan (11 shared papers)Da‐Yuan Zhu (3 shared papers)Da‐Yuan Zhu (8 shared papers)Peigen Xiao (1 shared paper)Shan‐Hao Jiang (6 shared papers)Guofu Chen (4 shared papers)Jinmian Han (2 shared papers)
- Journals
- Journal of Family Planning and Reproductive Health Care (3 papers)AIDS and Behavior (3 papers)BMJ Sexual & Reproductive Health (2 papers)Phytochemistry (2 papers)BJGP Open (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Richard Ma
57 papers receiving 1.9k citations
Richard Ma's Hit Papers
Peers
Comparison fields: 5 of 141
- Pharmacology 938
- Organic Chemistry 600
- Complementary and alternative medicine 116
- Pharmacology 98
- Plant Science 378
Countries citing papers authored by Richard Ma
This map shows the geographic impact of Richard Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Ma more than expected).
Fields of papers citing papers by Richard Ma
This network shows the impact of papers produced by Richard Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Ma. The network helps show where Richard Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Lycopodium alkaloids Hit paper breakdown → | 2004 | 588 |
| 2 | 2007 | 243 | |
| 3 | 2018 | 112 | |
| 4 | 2008 | 88 | |
| 5 | 2005 | 82 | |
| 6 | 2005 | 69 | |
| 7 | 2013 | 53 | |
| 8 | 2006 | 51 | |
| 9 | 2006 | 44 | |
| 10 | 2002 | 37 | |
| 11 | 2016 | 35 | |
| 12 | 2002 | 34 | |
| 13 | 2018 | 33 | |
| 14 | 1998 | 30 | |
| 15 | 2018 | 27 | |
| 16 | 2021 | 25 | |
| 17 | 2002 | 24 | |
| 18 | 2003 | 24 | |
| 19 | 2008 | 23 | |
| 20 | 2003 | 21 |
About Richard Ma
Richard Ma is a scholar working on Pharmacology, Molecular Biology, Infectious Diseases, Organic Chemistry and General Health Professions, having authored 61 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (14 papers), Chemical synthesis and alkaloids (6 papers), HIV/AIDS Research and Interventions (6 papers), LGBTQ Health, Identity, and Policy (4 papers), Botanical Research and Chemistry (4 papers), Insect Pest Control Strategies (3 papers), Plant Toxicity and Pharmacological Properties (3 papers) and Ginger and Zingiberaceae research (3 papers). The work is most often cited by research in Pharmacology (938 citations), Organic Chemistry (600 citations), Complementary and alternative medicine (116 citations), Pharmacology (98 citations) and Plant Science (378 citations). Richard Ma has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include David R. Gang, Chang‐Heng Tan, Da‐Yuan Zhu, Da‐Yuan Zhu, Peigen Xiao, Shan‐Hao Jiang, Guofu Chen, Jinmian Han, Zhengzhi Xie and Jiaqi Wang. Their work appears in journals such as Journal of Family Planning and Reproductive Health Care, AIDS and Behavior, BMJ Sexual & Reproductive Health, Phytochemistry and BJGP Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.